LD-2 disclosure · 3rd Quarter - Report
MYRIAD GENETICS, INC.
via MYRIAD GENETICS, INC.
Client
- Name
- MYRIAD GENETICS, INC.
- Location
- District of Columbia · United States of America
Registrant
- Firm
- MYRIAD GENETICS, INC.
- Description
- Clinical laboratory
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesBudget/Appropriations
H.R. 4366, the Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024 - report language related to precision medicine for treatment of depression in veterans
LobbyistsKIMBERLY LINTHICUM
Covered position (KIMBERLY LINTHICUM): Leg Director, Rep Bob Franks (1197-2000) Leg Correspondent, Rep Charles Taylor (1997) Leg Correspondent, Rep Bill Martini (1995-1996)
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
S708 - legislation to require CMS to issue a dear Medicaid director letter concerning precision medicine for depression
LobbyistsKIMBERLY LINTHICUM
Covered position (KIMBERLY LINTHICUM): Leg Director, Rep Bob Franks (1197-2000) Leg Correspondent, Rep Charles Taylor (1997) Leg Correspondent, Rep Bill Martini (1995-1996)
TargetedSENATE · HOUSE OF REPRESENTATIVES